hematopoiesis, and erythrocyte precursor maturation arrest. 1, 3, 9 Macrocytosis results from asynchronous development of the erythrocyte cytoplasm and nucleus. 1, 6, 9 Increased mean corpuscular volume (MCV) or increased red cell distribution width (RDW) can precede anemia. 1, 9, 10 Leukopoiesis and megakaryopoiesis can also be disrupted as a result of the bone marrow becoming hypercellular from impaired development and systemic release of hematopoietic cells. 3, 11 In severe cases, bone marrow failure and pancytopenia occur. 1, 11 Such hematologic abnormalities are rapidly reversible with oral or parenteral supplementation of cobalamin. 1, 3, 9, 12 An equivalent relationship between hypocobalaminemia or hypofolatemia and hematologic changes in small animal veterinary species has not been established, although reports of anisocytosis, macrocytosis, anemia, or pancytopenia in association with hypocobalaminemia do exist. [13] [14] [15] [16] [17] [18] [19] [20] In Giant Schnauzers, 16 Australian Shepherds, 19 Border
Collies, 20 and Beagles, 15 there is a congenital disorder analogous to
Imerslund-Grasbeck syndrome (IGS) in humans. In dogs with IGS, genetic mutations of the ileal cubam receptor lead to cobalamin deficiency, with subsequent nonregenerative anemia, erythrocyte anisocytosis, megaloblastic bone marrow, leukopenia, neutrophil hypersegmentation, and thrombocytopenia. [15] [16] [17] More subtle hematologic abnormalities consistent with dyserythropoiesis occur in Border
Collies with congenital cobalamin deficiency, particularly when only an automated blood cell count is done. 21 Cats with hypocobalaminemia might have macrocytosis, pancytopenia, and inverse relationships between serum cobalamin concentration and MCV and between serum MMA concentrations and hematocrit (HCT). 13, 14, 18, 22 These findings suggest a pathophysiology similar to the hematologic abnormalities of cobalamin-deficient people, although this has not been explored.
The primary objectives of our study were (1) to retrospectively determine the prevalence of anemia in a population of dogs that were screened for low cobalamin or folate concentrations and (2) to prospectively determine the prevalence of hypocobalaminemia and hypofolatemia and hematologic changes consistent with cobalamin and folate deficiencies in humans (nonregenerative anemia, macrocytosis, increased RDW) in a population of anemic dogs.
Given the fundamental role that B vitamins play in hematopoiesis, we hypothesized that in our retrospective population, dogs with hypocobalaminemia or hypofolatemia would be more likely to be anemic than normocobalaminemic and normofolatemic dogs, independent of disease states. Furthermore, in the prospectively examined population, dogs with nonregenerative anemia would more often be hypocobalaminemic or hypofolatemic than dogs with regenerative anemia, and hypocobalaminemic and hypofolatemic dogs would exhibit hematologic changes such as increased RDW more frequently than dogs with normal cobalamin and folate concentrations. 3 | RESULTS
| MATERIALS AND METHODS

| Retrospective Study
| Retrospective study
A total of 146 medical records of dogs that had a CBC and GI panel performed through IDEXX Laboratories on the same date were reviewed retrospectively. Thirty-two dogs were excluded, because of a history of cobalamin or folate supplementation (8 dogs), incomplete medical records within the electronic database (23), or enrollment in the prospective study (1) . Therefore, 114 dogs were included in the retrospective study. Thirty-four dogs were anemic (29.8%) and 80 (70.2%) were nonanemic, 44 (38.6%) were hypocobalaminemic, and 70 (61.4%) were normocobalaminemic, and 13 were hypofolatemic (11.5%), 100 were normofolatemic (88.5%), and 1 was missing folate data. Only 1 dog in the retrospective population had an increased MCV, and this case had a regenerative anemia.
There were no significant differences in the median age between dogs compared by HCT (anemic: 10.8 years, nonanemic: 7.3 years; P = .65), cobalamin (hypocobalaminemic: 9.8 years, normocobalaminemic: 7.9 years; P = .19), or folate status (hypofolatemic: 6.3 years, normofolatemic: 8.5 years; P = .37). Intact males, castrated males, intact females, and spayed females were evenly distributed (by HCT, P = .65; cobalamin, P = .42; folate, P = .38). Disease diagnoses included 63 dogs with GI disease (excluding GI neoplasia; 55.3%), Of 42 dogs, 18 (43%) had immune-mediated disease, 2 (5%) had GI disease, 5 (12%) had neoplasia, 12 (29%) had infectious/inflammatory disease, and 5 (12%) had other diseases. to human medicine, these hematologic changes are not a reliable consequence of hypocobalaminemia or hypofolatemia in dogs, suggesting that B vitamins might play a less prominent role in canine than in human erythropoiesis.
We evaluated retrospectively a population of 114 dogs that were screened for hypocobalaminemia or hypofolatemia, because of their high proportion (over 50%) of presumptive or confirmed primary GI disease. Although the underlying etiology was not confirmed in all cases, prevalence of hypocobalaminemia was high (38.6%), and more than 10% of dogs were hypofolatemic. This result matches with that of a previous study documenting hypocobalaminemia in 36% of dogs with chronic GI disease. 5 In our 42 prospectively enrolled dogs, GI disease was reported in only a small proportion (less than 5%). However, the prevalence of hypocobalaminemia was higher than in the retrospective group, approaching two-thirds of the population (62%), and hypofolatemia occurred in 22%. This could indicate a higher true prevalence of GI disease than was detected or the presence of other disease processes (eg, exocrine pancreatic insufficiency), medications (eg, antacids), or differences in diet that could have contributed to cobalamin and folate deficiencies in our prospective population. Macrocytosis might precede or occur with nonregenerative anemia in these patients; however, concurrent iron deficiency or chronic inflammatory disease can lead to anisocytosis without overt macrocytosis. 1, 3, 9, 10 A causal relationship between vitamin B deficiencies and anemia has not been established in small animals. 2 An exception in certain dog breeds is congenital hypocobalaminemia (eg, Giant
Schnauzers with IGS), resulting in hypocobalaminemia and marked hematologic changes from genetic mutations of ileal receptors, although macrocytosis has not been reported. [15] [16] [17] Pancytopenia and increased MCV associated with severe cobalamin deficiency have been recognized rarely in cats. 13, 14, 18, 23 Despite these findings in humans and specific small animals, the prevalence of anemia did not differ by cobalamin or folate status in our retrospective group. Furthermore, hypocobalaminemia was not significantly associated with nonregenerative anemia, and cobalamin concentration did not correlate with HCT or reticulocyte count. In contrast to our hypotheses, these results did not support a direct relationship between hypocobalaminemia or hypofolatemia and anemia.
We also prospectively examined several hematologic parameters 
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We elected to measure serum MMA concentrations in addition to cobalamin and folate in the prospective group to increase detection of cases with functional, cellular hypocobalaminemia. Because cobalamin is a necessary cofactor for methylmalonyl CoA mutase-mediated conversion of L-methylmalonyl CoA to succinyl CoA, increased MMA concentrations can be a more accurate, early indicator of functional hypocobalaminemia on a cellular level. 1, 5, 13, 23, 30 In our population, increased MMA was an uncommon finding (8/42 patients). Only 3 of 8 dogs (24%) with methylmalonic-acidemia had normal cobalamin concentrations, and of the remaining 5 dogs with increased MMA concentrations, all 5 cases had cobalamin concentrations below the reference interval. These findings are consistent with previous canine studies that have documented hypocobalaminemia without cellular cobalamin deficiency (increased MMA concentrations), although a negative correlation between serum MMA and cobalamin concentrations is typically expected. 5, 23 Low cobalamin can also cause functional folate deficiency because of impaired activation by cobalamindependent methionine synthase of folate to tetrahydrofolate, so that measurement of homocysteine concentrations in addition to MMA might have helped differentiate functional from true folate deficiency. 3, 30 In conclusion, the results of our study indicate that the association between cobalamin and folate deficiencies and macrocytic, non- 
